Hangzhou, China · Founded 2017 · In IPO Registration
Developer of a drug development approach designed to create therapies for autoimmune and inflammatory diseases affecting systemic and central nervous system conditions. Highlightll Pharma is based in Hangzhou, China and was founded in 2017. Its last reported valuation was $346 million in Nov 2025. It has raised $97.3 million.
Last reported valuation
$346.2M
Oct 2026
Priced at
—
Total raised
$97.3M
Last round
—
Cap table — not yet on record
Highlightll Pharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Highlightll Pharma with a free account
·The complete investor list: 11 names
·Watch Highlightll Pharma: the Monday email on marks, rounds and moves
